Evaluation of the 13C-methacetin breath test for quantitative liver function testing;Evaluation des 13C-methacetin-atemtests als quantitativer leberfunktionstest

Zeitschrift fur Gastroenterologie

Volumn 35, Issue 8, 1997, Pages 609-614

  Klatt, S ^a   Taut, C ^b   Mayer, D ^a   Adler, G ^b   Beckh, K ^a  

^a Klinikum Worms   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

13C methacetin; Breath test; Quantitative liver function test

Indexed keywords

4 ACETANISIDINE; CARBON 13; INDOCYANINE GREEN; ACETAMIDE DERIVATIVE; CARBON; DIAGNOSTIC AGENT;

ARTICLE; BREATH ANALYSIS; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; LIVER CIRRHOSIS; LIVER CLEARANCE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; QUANTITATIVE DIAGNOSIS; VIRUS HEPATITIS; ADULT; AGED; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING;

ACETAMIDES; ADULT; AGED; BREATH TESTS; CARBON RADIOISOTOPES; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0030612668     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG. The liver and portal hypertension. Philadelphia, W. B. Saunders Co., 1964: 50-1
2. Dickson ER, Grambsch PM, Fleming TR, Fisher DL, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989; 10: 1-7
3. Reichen J. Assessment of hepatic function with xenobiotics. Semin Liver Dis 1995; 15: 189-201
4. Monroe PS, Baker AL, Schneider JF et al. The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis. Hepatology 1982; 2: 317-22
5. Reichen J, Bianchi L, Frei PC et al. Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. J Hepatol 1994; 20: 168-74
6. Oellerich M, Burdelski M, Lautz HU et al. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. Ther Drug Monit 1990; 12: 219-26
7. Krumbiegel P, Teichmann B, Boehm G. (15N) Methacetin urine test: A method to study the development of hepatic detoxification capacity. Eur J Pediatr 1990; 149: 393-5
8. 2-methacetin breath test for hepatic function - a noninvasive approach. Hepatology 1984; 4: A350
9. 13C methacetin for the detection of alterations in hepatic drug metabo- lism. In: Klein ER, Klein PD. Stable Isotopes: Proceedings of the third international conference. New York, Academic Press 1979; 507-16
10. 13C methacetin breath test for evaluation of liver damage. Dig Dis Sci 1987; 4: 344-8
11. 13C-Methacetin-Atemtest zur quantitativen Leberfunktionsanalyse unterscheidet zuverlässig zwischen Leberzirrhose und nichtzirrhotischer Hepatopathie. Z Gastroenterol 1995; 33: 80
12. 2-methacetin breath test: A comparative analysis. Hepatology 1984; 4: A 351
13. Burdelski M, Oellerich M, Lamesch P et al. Evaluation of quantitative liver function tests in liver donors. Transplant Proc 1987; 19: 3838-9
14. 13C-methacetin. Eur J Nucl Med 1985; 10: 129-33
15. Stremmel W, Wojdat R, Groteguth M et al. Leberfunktionstests im klinischen Vergleich. Z Gastroenterol 1992; 30: 784-90